Alnawaiseh Maged, Rosentreter André, Eveslage Maria, Eter Nicole, Zumhagen Lars
J Refract Surg. 2015 Sep;31(9):614-8. doi: 10.3928/1081597X-20150820-07.
To determine long-term changes in corneal transparency after riboflavin-ultraviolet A-induced corneal collagen cross-linking (CXL).
Charts and anterior segment data of patients after CXL for progressive keratoconus were retrospectively reviewed. Patients were examined using the Scheimpflug-based Pentacam corneal densitometry module (Oculus Optikgeräte, Wetzlar, Germany) before CXL and at five postoperative follow-up visits: 1 to 3, 3 to 6, 6 to 12, 12 to 24, and 24 to 36 months.
Forty-two eyes of 28 patients (mean age: 27.9 ± 8.6 years) were included. Total corneal light backscatter was higher 1 to 3 months after CXL than before CXL (P < .001). There were significant differences, especially in the anterior (P < .001) and central (P < .001) layer at total diameter and posterior layer (P = .014) and the three central annuli at total corneal thickness (0 to 2 mm: P < .001; 2 to 6 mm: P < .001; 6 to 10 mm: P = .002). Total corneal light backscatter at total corneal thickness and total diameter faded over time following CXL. The backscatter was significantly lower 24 to 36 months after CXL than before CXL (P < .001).
Corneal densitometry peaks in the first months after CXL and returns to preoperative values approximately 1 year after CXL. Two years after CXL, corneal densitometry reaches values obtained for healthy, untreated corneas, thus achieving an improvement in corneal clarity over untreated keratoconic corneas.
确定核黄素-紫外线A诱导的角膜胶原交联(CXL)术后角膜透明度的长期变化。
对进行CXL治疗进行性圆锥角膜患者的病历和眼前节数据进行回顾性分析。在CXL术前及术后1至3、3至6、6至12、12至24和24至36个月的五次随访中,使用基于Scheimpflug原理的Pentacam角膜密度测量模块(德国韦茨拉尔Oculus Optikgeräte公司)对患者进行检查。
纳入28例患者的42只眼(平均年龄:27.9±8.6岁)。CXL术后1至3个月的角膜总光背散射高于术前(P<.001)。在总直径的前层(P<.001)和中央层(P<.001)、后层(P=.014)以及角膜总厚度的三个中央环带(0至2mm:P<.001;2至6mm:P<.001;6至10mm:P=.002)存在显著差异。CXL术后,角膜总厚度和总直径处的角膜总光背散射随时间逐渐减弱。CXL术后24至36个月的背散射显著低于术前(P<.001)。
角膜密度测量在CXL术后最初几个月达到峰值,并在CXL术后约1年恢复到术前值。CXL术后两年,角膜密度测量达到健康未治疗角膜的值,从而使圆锥角膜的角膜清晰度较未治疗者有所改善。